Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$657M |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$587M |
| 4 |
AstraZeneca
AZN
|
+$319M |
| 5 |
Snowflake
SNOW
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$323M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$273M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$121M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$98.6M |
| 5 |
JD.com
JD
|
+$89.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.6% |
| 4 | Consumer Discretionary | 10.97% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLYA
2626
DELISTED
Playa Hotels & Resorts
PLYA
| $241K | ﹤0.01% |
29,094
+22,901
| +370% | +$163K |
|
2627
Turning Point Brands
TPB
$1.74B
| $240K | ﹤0.01% |
5,025
+2,806
| +126% | +$135K |
|
2628
Syndax Pharmaceuticals
SNDX
$1.82B
| $239K | ﹤0.01% |
12,493
+7,450
| +148% | +$124K |
|
2629
Citi Trends
CTRN
$605M
| $238K | ﹤0.01% |
3,250
+1,750
| +117% | +$140K |
|
|
ATRS
2630
DELISTED
Antares Pharma, Inc.
ATRS
| $238K | ﹤0.01% |
65,341
+30,914
| +90% | +$125K |
|
2631
International Seaways
INSW
$4.57B
| $237K | ﹤0.01% |
12,985
+10,394
| +401% | +$177K |
|
2632
Barrett Business Services
BBSI
$804M
| $236K | ﹤0.01% |
12,368
+6,044
| +96% | +$113K |
|
|
MRSN
2633
DELISTED
Mersana Therapeutics
MRSN
| $236K | ﹤0.01% |
1,005
+445
| +79% | +$130K |
|
2634
Pampa Energía
PAM
$4.41B
| $236K | ﹤0.01% |
13,499
| – | – |
|
2635
AnaptysBio
ANAB
$1.68B
| $235K | ﹤0.01% |
8,663
+3,515
| +68% | +$89.2K |
|
2636
Rekor Systems
REKR
$91.7M
| $235K | ﹤0.01% |
20,426
+6,048
| +42% | +$54.9K |
|
|
HONE
2637
DELISTED
HarborOne Bancorp
HONE
| $234K | ﹤0.01% |
16,650
+9,986
| +150% | +$138K |
|
|
MRC
2638
DELISTED
MRC Global
MRC
| $233K | ﹤0.01% |
31,737
-41,839
| -57% | -$348K |
|
|
THR
2639
DELISTED
Thermon Group Holdings
THR
| $233K | ﹤0.01% |
13,428
+6,561
| +96% | +$109K |
|
2640
Alpha and Omega Semiconductor
AOSL
$1.08B
| $232K | ﹤0.01% |
7,385
+4,075
| +123% | +$113K |
|
2641
BrightView Holdings
BV
$1.07B
| $232K | ﹤0.01% |
15,684
+10,929
| +230% | +$167K |
|
2642
Replimune Group
REPL
$1.01B
| $231K | ﹤0.01% |
7,767
+4,409
| +131% | +$143K |
|
|
QIWI
2643
DELISTED
QIWI PLC
QIWI
| $230K | ﹤0.01% |
27,385
+12,918
| +89% | +$123K |
|
2644
Rigel Pharmaceuticals
RIGL
$750M
| $229K | ﹤0.01% |
6,305
+3,339
| +113% | +$131K |
|
2645
Gossamer Bio
GOSS
$87M
| $225K | ﹤0.01% |
17,838
+9,997
| +127% | +$92K |
|
2646
Waterstone Financial
WSBF
$375M
| $225K | ﹤0.01% |
10,952
+4,201
| +62% | +$83.6K |
|
2647
Byline Bancorp
BY
$1.76B
| $224K | ﹤0.01% |
9,118
+6,615
| +264% | +$158K |
|
2648
Banco Macro
BMA
$5.35B
| $222K | ﹤0.01% |
13,063
| – | – |
|
|
HTBK
2649
DELISTED
Heritage Commerce
HTBK
| $222K | ﹤0.01% |
19,035
+11,841
| +165% | +$132K |
|
|
KE
2650
Kimball Electronics
KE
$628M
| $222K | ﹤0.01% |
8,632
+4,980
| +136% | +$114K |
|
Similar funds
Legal & General Group's Q3 2021 Portfolio in Review
As of Q3 2021, Legal & General Group held 3,551 positions worth $308B, up 2.9% from $299B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Legal & General Group deployed $10.7B of net new capital in Q3 2021, opening 77 new positions and adding to 2,293 existing holdings. Its largest new stake was AstraZeneca: 2,738,007 shares worth $329M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $89.3M trimmed.
- Legal & General Group's largest Q3 2021 buy was AstraZeneca: 2,738,007 shares worth $329M.
- Legal & General Group added most to Microsoft in Q3 2021, an estimated $657M increase.
- Legal & General Group's biggest Q3 2021 reduction was JD.com, cutting an estimated $89.3M.
- Legal & General Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $323M.
- Legal & General Group's ten largest holdings make up 22% of its $308B portfolio in Q3 2021.
- Legal & General Group opened 77 new positions and closed 55 in Q3 2021.
- Legal & General Group's portfolio value rose 2.9% quarter-over-quarter to $308B.
Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.